Strand Therapeutics
Strand Therapeutics is a clinical stage biotechnology company utilizing synthetic biology to genetically program mRNA to deliver truly revolutionary immunotherapies to patients.
Building on the idea of creating smart therapies based on Boolean logic circuits, Strand was started by biological engineers working together at MIT who were seeking to apply the concept of the emerging field of mRNA therapeutics. Strand's technology is therapeutic-area and mRNA modality agnostic where therapeutic proteins are encoded onto modified, self-replicating, or circular mRNA backbones which in turn are programmed with cell-specific sensors and circuits.
Today, Strand has established multiple programmable mRNA platforms with one clinical stage asset and several programs in preclinical development as well as early discovery. Our lead program, STX-001, is currently being evaluated in a Phase 1 clinical trial for solid tumors. Our corporate headquarters is located in the Fenway district of Boston, Massachusetts.
Is Strand Therapeutics hiring?
Yes — Strand Therapeutics has 3 open jobs on JobsRadar right now. 1 of them were opened in the last 30 days. 3 of them disclose pay, with a median of $137,000 a year and most offers between $115,250 and $262,250. 1 were added in the last 24 hours; the board was last refreshed on September 18, 2026 at 06:22 UTC.
Frequently asked questions
- Is Strand Therapeutics hiring?
- Yes. Strand Therapeutics has 3 open jobs on JobsRadar as of September 18, 2026. 1 of them were opened in the last 30 days.
- What roles is Strand Therapeutics hiring for?
- Strand Therapeutics is hiring for roles in Technical Operations and Regulatory Sciences.
- What does Strand Therapeutics pay?
- Across the 3 Strand Therapeutics jobs that disclose pay, the median is $137,000 a year, and most offers fall between $115,250 and $262,250.
- How current are these listings?
- Every listing comes straight from the employer’s own careers system and is re-checked three times a day. This page was last updated on September 18, 2026 at 06:22 UTC.